Journals / Nöropsikiyatri Arşivi / 2015 / Cilt: 52 - Sayı: 1

Modafinil-Induced Psychosis: A Case Report

Modafinil'e Bağlı Psikoz: Bir Olgu Sunumu

Pages
99–101
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Modafinil using patients must be psychiatrically monitored for its potential psychotic effect even in previously healthy individuals and low doses

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Modafinil is used in the treatment of excessive day time sleepiness associated with several clinical conditions.
📊
Key Findings & Data:The cases in the literature are reported to develop mania or psychosis with 200-400 mg/day or higher doses.
💡
Conclusion & Impact:Modafinil using patients must be psychiatrically monitored for its potential psychotic effect even in previously healthy individuals and low doses
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Modafinil is used in the treatment of excessive day time sleepiness associated with several clinical conditions. It can also be used for affective stimulation for working late and/or concentrating for a long time. The reported cases of psychosis associated with modafinil use in the literature, have medical or psychiatric diorders. There is only one reported case without medical or psychiatric disorder but developed modafinil related psychosis, which is a case under simulated shift work in laboratory conditions. The cases in the literature are reported to develop mania or psychosis with 200-400 mg/day or higher doses. The case reported in this manuscript develop psychosis with 100 mg/day dosage. This case has no previous psychiatric and medical disorder history and not being on a shift work. The aim of modafinil use in this case was reported as increasing the concentration and performance while studying. Modafinil using patients must be psychiatrically monitored for its potential psychotic effect even in previously healthy individuals and low doses

Özet

Modafinil gündüz uykululuğu ile giden çeşitli klinik durumların tedavisinde kullanılmaktadır. Geç saatlere kadar çalışmak, uzun süre dikkat ve konsantrasyonunu devam ettirmek ve duygudurumunu canlandırmak isteyen bireyler tarafından da kullanılabilmektedir. Literatürde modafinil kullanımına bağlı psikoz geliştiği bildirilen olguların tıbbi veya psikiyatrik hastalık öyküleri bulunmaktadır. Tıbbi veya psikiyatrik hastalık öyküsü olmaksızın modafinil kullanımına bağlı psikoz geliştiği bildirilen bir olguda laboratuvar koşullarında vardiyalı iş simulasyonu yapılması sözkonusudur. Literatürdeki olgularda 200-400 mg/gün veya daha yüksek dozlarda psikoz veya mani ge-liştiği bildirilmektedir. Bu yazıda sunulan olguda tıbbi ve psikiyatrik hastalık öyküsü olmaksızın ders çalışma performansını arttırmak için kullanılan 100 mg/gün modafinil ile psikoz gelişmiştir. Sağlıklı bireyler de olsa, modafinil düşük dozlarda kullanılsa bile psikoz yapıcı riskinden dolayı hastaların dik-katli psikiyatrik izleminin yapılması gerekmektedir.

🔖

Cite This Article

AYTAŞ, Ö., YALVAÇ, H. D. (2015). Modafinil-Induced Psychosis: A Case Report. Nöropsikiyatri Arşivi, Cilt: 52 - Sayı: 1, 99–101. https://ajindex.com/articles/292345

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Kanal MG, Ozkan C, Doganavsargil O, Eryılmaz M. Late onset mania possibly related to modafinil use: A case report. Klinik Psikofarmakol Bulteni 2012; 22:71-74.
  2. Wesensten NJ, Killgore WD, Balkin TJ. Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation. J Sleep Res 2005; 14:255-266. [CrossRef] Keating GM, Raffin MJ. Modafinil: A review of its use in excessive sleepiness as- sociated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder. CNS Drugs 2005; 19:785-803. [CrossRef] Valentino RM, Foldvary-Schaefer N. Modafinil in the treatment of excessive daytime sleepiness. Cleve Clin J Med 2007; 74:561-6, s.568-571. Jasinski DR. An evaluation of the abuse potential of modafinil using methyl- phenidate as a reference. J Psychopharmacol 2000; 14:53-60. [CrossRef] Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disor- der. Biol Psychiatry 2004; 55:1031-1040.[CrossRef] Schwartz JR. Modafinil: new indications for wake promotion. Expert Opin Pharmacother 2005; 6:115-129. [CrossRef] Pary R, Lewis S, Matuschka PR, Rudzinskiy P, Safi M, Lippmann S. Attention deficit disorder in adults. Ann Clin Psychiatry 2002; 14:105-111. [CrossRef] Kim D. Practical use and risk of modafinil, a novel waking drug. Environ Health Toxicol 2012; 27:e2012-2007.
  3. Mariani JJ, Hart CL. Psychosis associated with modafinil and shift work. Am J Psychiatry 2005; 162:1983. [CrossRef] Wu P, Jones S, Ryan CJ, Michail D, Robinson TD. Modafinil-induced psychosis. Intern Med J 2008; 38:677-678. [CrossRef] Narendran R, Young CM, Valenti AM, Nickolova MK, Pristach CA. Is psychosis exacerbated by modafinil? Arch Gen Psychiatry 2002; 59:292-293. [CrossRef] Aggarwal A, Garg A, Jiloha RC. Psychotic relapse in a patient with schizophre- nia associated with modafinil therapy. Primary Psychiatry 2009; 16:26-27.
  4. Özer S, Demir B. Bir şizofreni hastasında klozapin tedavisine modafinil eklen- mesi ile ortaya çıkan hipomani. Arch Neuropsychiatr 2010; 47:171-173.
  5. Prado E, Paholpak P, Ngo M, Porter V, Apostolova LG, Marrocos R, Ringman JM. Agitation and psychosis associated with dementia with lewy bodies exac- erbated by modafinil use. Am J Alzheimer Dis Other Demen 2012; 27:468- 473. [CrossRef] McClellan KJ, Spencer CM. Modafinil: a review of its pharmacology and clinical effi- cacy in the management of narcolepsy. CNS Drugs 1998; 9:311-324. [Cro